WebSep 13, 2024 · In patients with osteomyelitis, prosthetic joint infection, vertebral osteomyelitis and acute septic arthritis dalbavancin was mainly used as sequential … WebApr 1, 2024 · Dalbavancin offers potential for outpatient parenteral antibiotic therapy (OPAT) of patients with bacterial infections such as infective endocarditis or osteomyelitis which otherwise require long hospitalization due to daily administration of intravenous antibiotics over several weeks ( Bassetti et al., 2024, Dunne et al., 2015 ).
National Center for Biotechnology Information
WebDec 10, 2024 · Background Osteomyelitis is a challenging infection that can involve 4-6 weeks of intravenous (IV) antibiotics. [...] Key Method Patients were randomized 7:1 to dalbavancin (1500 mg IV on days 1 and 8) or standard of care (SOC) for osteomyelitis (oral or IV) per investigator judgment for 4-6 weeks. The primary endpoint was clinical … WebMar 1, 2024 · The study will compare dalbavancin to standard of care antibiotic therapy for the completion of therapy in patients with complicated bacteremia or right-sided native … lampu malam motor
Multiple Weekly Dalbavancin Dosing for the Treatment of Native ...
WebDec 19, 2024 · Dalbavancin is a novel lipoglycopeptide antibiotic, characterized by a broad spectrum of activity against Gram-positive cocci. ... Dalbavancin spondylodiscitis treatment antibiotic case series osteoarticular infection vertebral osteomyelitis. Disclosure statement. EDM reports research funding for his Institution from MSD, Pfizer, Advanz pharma ... WebApr 1, 2024 · Dalbavancin has promising pharmacokinetic/pharmacodynamic and safety data to be considered in the treatment of osteomyelitis caused by S. aureus. … WebDec 15, 2024 · The most common indication was osteomyelitis, including 14 cases of vertebral osteomyelitis (Table 2). The most common causative organism was Staphylococcus aureus, 23 (43%) cases due to MRSA and ... jesus vs goku gif